Conference Coverage

CKD triples risk of bad outcomes in HIV


 

REPORTING FROM CROI


The subjects were all participants in the D:A:D project [Data Collection on Adverse Events of Anti-HIV Drugs], an ongoing international cohort study based at the University of Copenhagen, and funded by pharmaceutical companies, among others.

Dr. Ryom had no disclosures.

SOURCE: Ryom L et al. CROI, Abstract 75.

Pages

Recommended Reading

HIV+ dialysis patients: Differential survival by race compared with HIV/HCV coinfection
Federal Practitioner
MicroRNAs flag liver damage in HIV-, HCV-infected persons
Federal Practitioner
HSV-2 Has Little to No Effect on HIV Progression
Federal Practitioner
PrEP Prescriptions Are on the Rise
Federal Practitioner
Ultra-Short Tuberculosis Prophylaxis
Federal Practitioner
Getting At-Risk Kids to Change Sexual Behavior
Federal Practitioner
Targeting the Gut in Patients With HIV
Federal Practitioner
HIV infection linked to higher risk of non-melanoma skin cancer
Federal Practitioner
Most HIV patients need treatment for acute HCV
Federal Practitioner
What Ascites Might Mean in a Patient With HIV
Federal Practitioner